 | • レポートコード：MRC2312MG06697 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のナノベースドラッグデリバリーシステム市場規模と予測を収録しています。・世界のナノベースドラッグデリバリーシステム市場：売上、2018年-2023年、2024年-2029年 ・世界のナノベースドラッグデリバリーシステム市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のナノベースドラッグデリバリーシステム市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「リポソーム医薬品」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 ナノベースドラッグデリバリーシステムのグローバル主要企業は、Johnson & Johnson、 Sun Pharmaceutical、 CSPC、 Kinyond、 Teva、 Fudan-Zhangjiang、 Zydus Cadila、 TTY Biopharma、 Pacira、 Luye Pharma、 Leadiant Biosciences、 Ipsen、 Sayre Therapeutics、 Jazz、 Alnylam、 Bausch Health、 Acrotech Biopharma、 Takeda、 Chiesi Farmaceutici、 Gilead Sciencesなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、ナノベースドラッグデリバリーシステムのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のナノベースドラッグデリバリーシステム市場：タイプ別、2018年-2023年、2024年-2029年 世界のナノベースドラッグデリバリーシステム市場：タイプ別市場シェア、2022年 ・リポソーム医薬品、脂質ナノ粒子医薬品 世界のナノベースドラッグデリバリーシステム市場：用途別、2018年-2023年、2024年-2029年 世界のナノベースドラッグデリバリーシステム市場：用途別市場シェア、2022年 ・病院、小売薬局、その他 世界のナノベースドラッグデリバリーシステム市場：地域・国別、2018年-2023年、2024年-2029年 世界のナノベースドラッグデリバリーシステム市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるナノベースドラッグデリバリーシステムのグローバル売上、2018年-2023年 ・主要企業におけるナノベースドラッグデリバリーシステムのグローバル売上シェア、2022年 ・主要企業におけるナノベースドラッグデリバリーシステムのグローバル販売量、2018年-2023年 ・主要企業におけるナノベースドラッグデリバリーシステムのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Johnson & Johnson、 Sun Pharmaceutical、 CSPC、 Kinyond、 Teva、 Fudan-Zhangjiang、 Zydus Cadila、 TTY Biopharma、 Pacira、 Luye Pharma、 Leadiant Biosciences、 Ipsen、 Sayre Therapeutics、 Jazz、 Alnylam、 Bausch Health、 Acrotech Biopharma、 Takeda、 Chiesi Farmaceutici、 Gilead Sciences ************************************************************* ・調査・分析レポートの概要 ナノベースドラッグデリバリーシステム市場の定義 市場セグメント 世界のナノベースドラッグデリバリーシステム市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のナノベースドラッグデリバリーシステム市場規模 世界のナノベースドラッグデリバリーシステム市場規模：2022年 VS 2029年 世界のナノベースドラッグデリバリーシステム市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのナノベースドラッグデリバリーシステムの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のナノベースドラッグデリバリーシステム製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：リポソーム医薬品、脂質ナノ粒子医薬品 ナノベースドラッグデリバリーシステムのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、小売薬局、その他 ナノベースドラッグデリバリーシステムの用途別グローバル売上・予測 ・地域別市場分析 地域別ナノベースドラッグデリバリーシステム市場規模 2022年と2029年 地域別ナノベースドラッグデリバリーシステム売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Johnson & Johnson、 Sun Pharmaceutical、 CSPC、 Kinyond、 Teva、 Fudan-Zhangjiang、 Zydus Cadila、 TTY Biopharma、 Pacira、 Luye Pharma、 Leadiant Biosciences、 Ipsen、 Sayre Therapeutics、 Jazz、 Alnylam、 Bausch Health、 Acrotech Biopharma、 Takeda、 Chiesi Farmaceutici、 Gilead Sciences ... |
This research report provides a comprehensive analysis of the Nano based Drug Delivery System market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Nano based Drug Delivery System market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Nano based Drug Delivery System, challenges faced by the industry, and potential opportunities for market players.
The global Nano based Drug Delivery System market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Nano based Drug Delivery System market presents opportunities for various stakeholders, including Hospital, Retail Pharmacy. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Nano based Drug Delivery System market. Additionally, the growing consumer demand present avenues for market expansion.
The global Nano based Drug Delivery System market was valued at US$ 4733.8 million in 2022 and is projected to reach US$ 9568 million by 2029, at a CAGR of 10.5% during the forecast period.
The Nano-based Drug Delivery System Market is driven by the demand for more effective and targeted drug delivery methods. Nano-based systems offer improved drug solubility, bioavailability, and reduced side effects. However, a significant challenge is the complexity of nanotechnology and the need for rigorous safety assessments and regulatory approvals. Ensuring the safety and biocompatibility of nano-based drug delivery systems is crucial. Additionally, competition in the market and cost considerations pose challenges, necessitating a balance between affordability and the development of advanced nano-based drug delivery technologies to meet the evolving needs of the pharmaceutical industry while ensuring patient well-being.
Key Features:
The research report on the Nano based Drug Delivery System market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Nano based Drug Delivery System market.
Market Overview: The report provides a comprehensive overview of the Nano based Drug Delivery System market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Liposomes Drugs, Lipid Nanoparticle Drugs), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Nano based Drug Delivery System market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Nano based Drug Delivery System market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Nano based Drug Delivery System market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Nano based Drug Delivery System market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Nano based Drug Delivery System market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Nano based Drug Delivery System market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Nano based Drug Delivery System, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Nano based Drug Delivery System market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Nano based Drug Delivery System market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Liposomes Drugs
Lipid Nanoparticle Drugs
Market segment by Application
Hospital
Retail Pharmacy
Other
Global Nano based Drug Delivery System Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Johnson & Johnson
Sun Pharmaceutical
CSPC
Kinyond
Teva
Fudan-Zhangjiang
Zydus Cadila
TTY Biopharma
Pacira
Luye Pharma
Leadiant Biosciences
Ipsen
Sayre Therapeutics
Jazz
Alnylam
Bausch Health
Acrotech Biopharma
Takeda
Chiesi Farmaceutici
Gilead Sciences
Outline of Major Chapters:
Chapter 1: Introduces the definition of Nano based Drug Delivery System, market overview.
Chapter 2: Global Nano based Drug Delivery System market size in revenue.
Chapter 3: Detailed analysis of Nano based Drug Delivery System company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Nano based Drug Delivery System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Nano based Drug Delivery System Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nano based Drug Delivery System Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nano based Drug Delivery System Overall Market Size
2.1 Global Nano based Drug Delivery System Market Size: 2022 VS 2029
2.2 Global Nano based Drug Delivery System Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Nano based Drug Delivery System Players in Global Market
3.2 Top Global Nano based Drug Delivery System Companies Ranked by Revenue
3.3 Global Nano based Drug Delivery System Revenue by Companies
3.4 Top 3 and Top 5 Nano based Drug Delivery System Companies in Global Market, by Revenue in 2022
3.5 Global Companies Nano based Drug Delivery System Product Type
3.6 Tier 1, Tier 2 and Tier 3 Nano based Drug Delivery System Players in Global Market
3.6.1 List of Global Tier 1 Nano based Drug Delivery System Companies
3.6.2 List of Global Tier 2 and Tier 3 Nano based Drug Delivery System Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Nano based Drug Delivery System Market Size Markets, 2022 & 2029
4.1.2 Liposomes Drugs
4.1.3 Lipid Nanoparticle Drugs
4.2 By Type – Global Nano based Drug Delivery System Revenue & Forecasts
4.2.1 By Type – Global Nano based Drug Delivery System Revenue, 2018-2023
4.2.2 By Type – Global Nano based Drug Delivery System Revenue, 2024-2029
4.2.3 By Type – Global Nano based Drug Delivery System Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Nano based Drug Delivery System Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Other
5.2 By Application – Global Nano based Drug Delivery System Revenue & Forecasts
5.2.1 By Application – Global Nano based Drug Delivery System Revenue, 2018-2023
5.2.2 By Application – Global Nano based Drug Delivery System Revenue, 2024-2029
5.2.3 By Application – Global Nano based Drug Delivery System Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Nano based Drug Delivery System Market Size, 2022 & 2029
6.2 By Region – Global Nano based Drug Delivery System Revenue & Forecasts
6.2.1 By Region – Global Nano based Drug Delivery System Revenue, 2018-2023
6.2.2 By Region – Global Nano based Drug Delivery System Revenue, 2024-2029
6.2.3 By Region – Global Nano based Drug Delivery System Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Nano based Drug Delivery System Revenue, 2018-2029
6.3.2 US Nano based Drug Delivery System Market Size, 2018-2029
6.3.3 Canada Nano based Drug Delivery System Market Size, 2018-2029
6.3.4 Mexico Nano based Drug Delivery System Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Nano based Drug Delivery System Revenue, 2018-2029
6.4.2 Germany Nano based Drug Delivery System Market Size, 2018-2029
6.4.3 France Nano based Drug Delivery System Market Size, 2018-2029
6.4.4 U.K. Nano based Drug Delivery System Market Size, 2018-2029
6.4.5 Italy Nano based Drug Delivery System Market Size, 2018-2029
6.4.6 Russia Nano based Drug Delivery System Market Size, 2018-2029
6.4.7 Nordic Countries Nano based Drug Delivery System Market Size, 2018-2029
6.4.8 Benelux Nano based Drug Delivery System Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Nano based Drug Delivery System Revenue, 2018-2029
6.5.2 China Nano based Drug Delivery System Market Size, 2018-2029
6.5.3 Japan Nano based Drug Delivery System Market Size, 2018-2029
6.5.4 South Korea Nano based Drug Delivery System Market Size, 2018-2029
6.5.5 Southeast Asia Nano based Drug Delivery System Market Size, 2018-2029
6.5.6 India Nano based Drug Delivery System Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Nano based Drug Delivery System Revenue, 2018-2029
6.6.2 Brazil Nano based Drug Delivery System Market Size, 2018-2029
6.6.3 Argentina Nano based Drug Delivery System Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Nano based Drug Delivery System Revenue, 2018-2029
6.7.2 Turkey Nano based Drug Delivery System Market Size, 2018-2029
6.7.3 Israel Nano based Drug Delivery System Market Size, 2018-2029
6.7.4 Saudi Arabia Nano based Drug Delivery System Market Size, 2018-2029
6.7.5 UAE Nano based Drug Delivery System Market Size, 2018-2029
7 Nano based Drug Delivery System Companies Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Company Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Nano based Drug Delivery System Major Product Offerings
7.1.4 Johnson & Johnson Nano based Drug Delivery System Revenue in Global Market (2018-2023)
7.1.5 Johnson & Johnson Key News & Latest Developments
7.2 Sun Pharmaceutical
7.2.1 Sun Pharmaceutical Company Summary
7.2.2 Sun Pharmaceutical Business Overview
7.2.3 Sun Pharmaceutical Nano based Drug Delivery System Major Product Offerings
7.2.4 Sun Pharmaceutical Nano based Drug Delivery System Revenue in Global Market (2018-2023)
7.2.5 Sun Pharmaceutical Key News & Latest Developments
7.3 CSPC
7.3.1 CSPC Company Summary
7.3.2 CSPC Business Overview
7.3.3 CSPC Nano based Drug Delivery System Major Product Offerings
7.3.4 CSPC Nano based Drug Delivery System Revenue in Global Market (2018-2023)
7.3.5 CSPC Key News & Latest Developments
7.4 Kinyond
7.4.1 Kinyond Company Summary
7.4.2 Kinyond Business Overview
7.4.3 Kinyond Nano based Drug Delivery System Major Product Offerings
7.4.4 Kinyond Nano based Drug Delivery System Revenue in Global Market (2018-2023)
7.4.5 Kinyond Key News & Latest Developments
7.5 Teva
7.5.1 Teva Company Summary
7.5.2 Teva Business Overview
7.5.3 Teva Nano based Drug Delivery System Major Product Offerings
7.5.4 Teva Nano based Drug Delivery System Revenue in Global Market (2018-2023)
7.5.5 Teva Key News & Latest Developments
7.6 Fudan-Zhangjiang
7.6.1 Fudan-Zhangjiang Company Summary
7.6.2 Fudan-Zhangjiang Business Overview
7.6.3 Fudan-Zhangjiang Nano based Drug Delivery System Major Product Offerings
7.6.4 Fudan-Zhangjiang Nano based Drug Delivery System Revenue in Global Market (2018-2023)
7.6.5 Fudan-Zhangjiang Key News & Latest Developments
7.7 Zydus Cadila
7.7.1 Zydus Cadila Company Summary
7.7.2 Zydus Cadila Business Overview
7.7.3 Zydus Cadila Nano based Drug Delivery System Major Product Offerings
7.7.4 Zydus Cadila Nano based Drug Delivery System Revenue in Global Market (2018-2023)
7.7.5 Zydus Cadila Key News & Latest Developments
7.8 TTY Biopharma
7.8.1 TTY Biopharma Company Summary
7.8.2 TTY Biopharma Business Overview
7.8.3 TTY Biopharma Nano based Drug Delivery System Major Product Offerings
7.8.4 TTY Biopharma Nano based Drug Delivery System Revenue in Global Market (2018-2023)
7.8.5 TTY Biopharma Key News & Latest Developments
7.9 Pacira
7.9.1 Pacira Company Summary
7.9.2 Pacira Business Overview
7.9.3 Pacira Nano based Drug Delivery System Major Product Offerings
7.9.4 Pacira Nano based Drug Delivery System Revenue in Global Market (2018-2023)
7.9.5 Pacira Key News & Latest Developments
7.10 Luye Pharma
7.10.1 Luye Pharma Company Summary
7.10.2 Luye Pharma Business Overview
7.10.3 Luye Pharma Nano based Drug Delivery System Major Product Offerings
7.10.4 Luye Pharma Nano based Drug Delivery System Revenue in Global Market (2018-2023)
7.10.5 Luye Pharma Key News & Latest Developments
7.11 Leadiant Biosciences
7.11.1 Leadiant Biosciences Company Summary
7.11.2 Leadiant Biosciences Business Overview
7.11.3 Leadiant Biosciences Nano based Drug Delivery System Major Product Offerings
7.11.4 Leadiant Biosciences Nano based Drug Delivery System Revenue in Global Market (2018-2023)
7.11.5 Leadiant Biosciences Key News & Latest Developments
7.12 Ipsen
7.12.1 Ipsen Company Summary
7.12.2 Ipsen Business Overview
7.12.3 Ipsen Nano based Drug Delivery System Major Product Offerings
7.12.4 Ipsen Nano based Drug Delivery System Revenue in Global Market (2018-2023)
7.12.5 Ipsen Key News & Latest Developments
7.13 Sayre Therapeutics
7.13.1 Sayre Therapeutics Company Summary
7.13.2 Sayre Therapeutics Business Overview
7.13.3 Sayre Therapeutics Nano based Drug Delivery System Major Product Offerings
7.13.4 Sayre Therapeutics Nano based Drug Delivery System Revenue in Global Market (2018-2023)
7.13.5 Sayre Therapeutics Key News & Latest Developments
7.14 Jazz
7.14.1 Jazz Company Summary
7.14.2 Jazz Business Overview
7.14.3 Jazz Nano based Drug Delivery System Major Product Offerings
7.14.4 Jazz Nano based Drug Delivery System Revenue in Global Market (2018-2023)
7.14.5 Jazz Key News & Latest Developments
7.15 Alnylam
7.15.1 Alnylam Company Summary
7.15.2 Alnylam Business Overview
7.15.3 Alnylam Nano based Drug Delivery System Major Product Offerings
7.15.4 Alnylam Nano based Drug Delivery System Revenue in Global Market (2018-2023)
7.15.5 Alnylam Key News & Latest Developments
7.16 Bausch Health
7.16.1 Bausch Health Company Summary
7.16.2 Bausch Health Business Overview
7.16.3 Bausch Health Nano based Drug Delivery System Major Product Offerings
7.16.4 Bausch Health Nano based Drug Delivery System Revenue in Global Market (2018-2023)
7.16.5 Bausch Health Key News & Latest Developments
7.17 Acrotech Biopharma
7.17.1 Acrotech Biopharma Company Summary
7.17.2 Acrotech Biopharma Business Overview
7.17.3 Acrotech Biopharma Nano based Drug Delivery System Major Product Offerings
7.17.4 Acrotech Biopharma Nano based Drug Delivery System Revenue in Global Market (2018-2023)
7.17.5 Acrotech Biopharma Key News & Latest Developments
7.18 Takeda
7.18.1 Takeda Company Summary
7.18.2 Takeda Business Overview
7.18.3 Takeda Nano based Drug Delivery System Major Product Offerings
7.18.4 Takeda Nano based Drug Delivery System Revenue in Global Market (2018-2023)
7.18.5 Takeda Key News & Latest Developments
7.19 Chiesi Farmaceutici
7.19.1 Chiesi Farmaceutici Company Summary
7.19.2 Chiesi Farmaceutici Business Overview
7.19.3 Chiesi Farmaceutici Nano based Drug Delivery System Major Product Offerings
7.19.4 Chiesi Farmaceutici Nano based Drug Delivery System Revenue in Global Market (2018-2023)
7.19.5 Chiesi Farmaceutici Key News & Latest Developments
7.20 Gilead Sciences
7.20.1 Gilead Sciences Company Summary
7.20.2 Gilead Sciences Business Overview
7.20.3 Gilead Sciences Nano based Drug Delivery System Major Product Offerings
7.20.4 Gilead Sciences Nano based Drug Delivery System Revenue in Global Market (2018-2023)
7.20.5 Gilead Sciences Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
